Gross margin of the global top 20 pharmaceutical companies in 2018
Gross margin based ranking of top pharmaceutical companies 2018
Among top pharmaceutical companies in 2018, Celgene had the highest gross margin, followed by Novo Nordisk. Celgene’s gross margin in 2018 was 93.1 percent, while Novo Nordisk's gross margin at that time was about 88 percent. Gross margin can be defined as the revenue of a company less the cost of goods sold, divided by revenue. Gross margin is a representation of profit. The higher the gross margin, the more power a company has to raise prices.

Top pharmaceutical companies

Pharmaceutical companies can be ranked in other ways as well. As of 2018, Pfizer and Roche were the top-ranked pharmaceutical companies based on prescription sales. Research and development spending is another way in which pharmaceuticals can be ranked. Among global top companies, AstraZeneca and Eli Lilly were the leading pharmaceutical companies based on research and development spending as a portion of revenue in 2018.

Company spotlight: Novartis

Novartis, another leading pharmaceutical company based in Switzerland, was the second leading biotech and pharmaceutical company based on market capitalization as of 2019. Novartis has experienced distinct regional successes with Europe and the United States being the top revenue generators for Novartis. Novartis has experienced significant revenue growth from pharmaceuticals since 2009.
Gross margin of the global top 20 pharmaceutical companies in 2018
Gross margin
Celgene93.1%
Novo Nordisk88.1%
Amgen82.8%
Biogen81.8%
Gilead78.2%
AbbVie76.9%
Eli Lilly73.8%
AstraZenca71.8%
Bristol-Myers Squibb71.3%
Roche70.7%
Pfizer70.2%
Merck & Co.69.2%
GlaxoSmithKline67.9%
Johnson & Johnson66.7%
Novartis64.5%
Sanofi60.2%
Endo45.8%
Allergan44.2%
Teva44%
Mylan38%
Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

September 2019

Region

Worldwide

Survey time period

2018

Open this statistic in...
Gross margin based ranking of top pharmaceutical companies 2018
Among top pharmaceutical companies in 2018, Celgene had the highest gross margin, followed by Novo Nordisk. Celgene’s gross margin in 2018 was 93.1 percent, while Novo Nordisk's gross margin at that time was about 88 percent. Gross margin can be defined as the revenue of a company less the cost of goods sold, divided by revenue. Gross margin is a representation of profit. The higher the gross margin, the more power a company has to raise prices.

Top pharmaceutical companies

Pharmaceutical companies can be ranked in other ways as well. As of 2018, Pfizer and Roche were the top-ranked pharmaceutical companies based on prescription sales. Research and development spending is another way in which pharmaceuticals can be ranked. Among global top companies, AstraZeneca and Eli Lilly were the leading pharmaceutical companies based on research and development spending as a portion of revenue in 2018.

Company spotlight: Novartis

Novartis, another leading pharmaceutical company based in Switzerland, was the second leading biotech and pharmaceutical company based on market capitalization as of 2019. Novartis has experienced distinct regional successes with Europe and the United States being the top revenue generators for Novartis. Novartis has experienced significant revenue growth from pharmaceuticals since 2009.
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Statistics on "Teva"
  • Global positioning
The most important statistics
  • Key numbers
  • Regions and segments
  • Other
Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.